| Suche Service: |
|
Popular Städte Zürich Basel Winterthur Bern Luzern St. Gallen Genève Lugano Thun Frauenfeld Neuchâtel Schaffhausen Chur Zug Fribourg La Chaux-De-Fonds Dübendorf Olten Vevey Bellinzona |
|
Anzeige: |
| Anzeige: |
1228 Plan-Les-Ouates Chemin Des Aulx 16
Med Discovery Sa Karte
Med Discovery Sa
Telefon: (022) 706 17 54
Webseite (med-discovery.com)
Email Addresse: [javascript protected email address]
Anzeige:
behörden und bildung, wissenschaft und forschung, forschung, wissenschaft, bildung, biotechnologie
Dienstleistung Kategorien
behörden und bildung wissenschaft und forschung forschung wissenschaft bildung biotechnologieBezogene Services
Anzeige:Med Discovery SA - The Onco-Urology Company ; About us Pipeline Intellectual Property Partners News & Publications Contact Us ; ; Our Mission
Med Discovery is a Swiss biopharmaceutical company dedicated to the discovery and the development of highly specific treatments for uro-genital cancers. Our strategy is to develop protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways. To achieve this we are leveraging a unique in-house expertise in kallikreins, the biggest class of human proteases, combined with an international network in clinical urology.
Our proprietary technology platform to produce protease inhibitorsallows Med Discovery to target cancers or other diseases where there is a lack of specific treatment. Using this approach, Med Discovery intends to become a leading research and development biotech company in the uro-genital field, developing products both in-house and with appropriate partners.
; News
Meet Med Discovery at Biotech in Europe Investor Forum and BioBusiness Network 2010.
Read more
;
; ; ;
MED DISCOVERY SA | chemin des Croisettes 12 | 1066 Epalinges | Switzerland | Tél +41 21 651 90 76 | [email protected]
Med Discovery is a Swiss biopharmaceutical company dedicated to the discovery and the development of highly specific treatments for uro-genital cancers. Our strategy is to develop protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways. To achieve this we are leveraging a unique in-house expertise in kallikreins, the biggest class of human proteases, combined with an international network in clinical urology.
Our proprietary technology platform to produce protease inhibitorsallows Med Discovery to target cancers or other diseases where there is a lack of specific treatment. Using this approach, Med Discovery intends to become a leading research and development biotech company in the uro-genital field, developing products both in-house and with appropriate partners.
; News
Meet Med Discovery at Biotech in Europe Investor Forum and BioBusiness Network 2010.
Read more
;
; ; ;
MED DISCOVERY SA | chemin des Croisettes 12 | 1066 Epalinges | Switzerland | Tél +41 21 651 90 76 | [email protected]
Anzeige: